• Candel Therapeutics appointed Martine Zimmermann to its board, effective September 8, 2026.
• Zimmermann previously served as executive vice president at Inventiva and brings more than 30 years of industry experience.
• Maria Ostrovsky was appointed general counsel in October, effective November 3, 2026.
• Ostrovsky previously served as senior vice president, general counsel and chief compliance officer at Deciphera Pharmaceuticals, contributing to two global product launches.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611121605PRIMZONEFULLFEED9876705) on November 12, 2026, and is solely responsible for the information contained therein.